STOCK TITAN

Cambridge Acquisition Corp SEC Filings

CAQUU NASDAQ

Welcome to our dedicated page for Cambridge Acquisition SEC filings (Ticker: CAQUU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Cambridge Acquisition Corp.'s SEC filings document its SPAC capital structure, listed securities, initial public offering, material-event reports and governance status. The filings identify the company's units, Class A ordinary shares and warrants registered on Nasdaq, including the unit composition and the warrant exercise terms.

The company's 8-K filings also describe offering-related events, material definitive agreement disclosures, emerging growth company status and corporate information for a Cayman Islands blank-check issuer headquartered in Boston. These records center on public-company formation, securities registration, capital structure and blank-check company disclosure obligations.

Rhea-AI Summary

Cam-Phung Michael Tam reported open-market purchase transactions in a Form 4 filing for CAQUU. The filing lists transactions totaling 495,500 shares at a weighted average price of $10.00 per share. Following the reported transactions, holdings were 495,500 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cambridge Acquisition Corp., a newly formed SPAC, completed its initial public offering of 23,000,000 units at $10.00 per unit, generating $230,000,000 in gross proceeds. Each unit includes one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share.

The company simultaneously sold 495,500 private units to its sponsor at $10.00 per unit for $4,955,000. As of February 9, 2026, $230,000,000, including $8,050,000 in deferred underwriting commissions, was placed in a trust account for the benefit of public shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cambridge Acquisition Corp. submitted a Form 3 identifying Bradley Christopher as a director of the company. The provided data does not list any share purchase, sale, or other insider transactions, and no share amounts are shown for this reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Cambridge Acquisition Corp. is offering 20,000,000 units at $10.00 per unit for an aggregate public offering of $200,000,000 (or $230,000,000 if the underwriters’ overallotment option is exercised in full). Each unit consists of one Class A ordinary share and one‑third of one redeemable warrant; whole warrants will be exercisable to purchase one Class A ordinary share at an exercise price of $11.50, subject to adjustment.

The prospectus states that $200,000,000 (or $230,000,000) of the offering proceeds will be held in a U.S. trust account pending an initial business combination, public shareholders will have redemption rights upon completion of a business combination, and sponsor founder shares and private placement units create potential dilution and conflict‑of‑interest considerations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many Cambridge Acquisition (CAQUU) SEC filings are available on StockTitan?

StockTitan tracks 17 SEC filings for Cambridge Acquisition (CAQUU), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cambridge Acquisition (CAQUU)?

The most recent SEC filing for Cambridge Acquisition (CAQUU) was filed on February 10, 2026.